INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Ciudad de México, MéxicoPublicaciones en colaboración con investigadores/as de Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (10)
2022
-
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Liver International, Vol. 42, Núm. 8, pp. 1891-1901
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis
Advances in Therapy, Vol. 37, Núm. 12, pp. 4996-5009
2019
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
2016
-
Efficacious In Vitro and In Vivo Effects of Dihydrosphingosine–Ethambutol Analogues Against Susceptible and Multi-drug-resistant Mycobacterium tuberculosis
Archives of Medical Research, Vol. 47, Núm. 4, pp. 262-270
2009
-
Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 19, pp. 5764-5768
2000
-
Anetoderma in systemic lupus erythematosus: Relationship to antiphospholipid antibodies
Lupus, Vol. 9, Núm. 7, pp. 545-547